23Serious

Biotech

Ask VT AI

View News Summary

Michelle Obama's new fashion memoir 'The Look' reclaims her personal narrative and explores themes of confidence, identity, and beauty standards.
UK inflation data error overstates April figures, raising concerns about accuracy of economic statistics.
Ciena reports strong revenue growth, but earnings miss expectations as networking segment shines and company sets ambitious 2025 target.

20 hours

First 100 Days

See how you scored in predicting Trump's first 100 days

Latest News

HCW Biologics Secures $7M License Deal with WY Biotech

100% left coverage1 source

HCW Biologics Secures $7M License Deal with WY Biotech

100% left coverage1 source

HCW Biologics Secures $7M License Deal with WY Biotech

HCW Biologics Secures $7M License Deal with WY Biotech

Insilico AI-Designed Drug Shows Efficacy in Lung Disease Phase 2a Trial

50% center coverage2 sources

Insilico AI-Designed Drug Shows Efficacy in Lung Disease Phase 2a Trial

50% center coverage2 sources

Insilico AI-Designed Drug Shows Efficacy in Lung Disease Phase 2a Trial

Insilico AI-Designed Drug Shows Efficacy in Lung Disease Phase 2a Trial

Merus Shares Surge 40% on Promising Cancer Data Amid Biotech Sector Uncertainty

100% center coverage1 source

Merus Shares Surge 40% on Promising Cancer Data Amid Biotech Sector Uncertainty

100% center coverage1 source

Merus Shares Surge 40% on Promising Cancer Data Amid Biotech Sector Uncertainty

Merus Shares Surge 40% on Promising Cancer Data Amid Biotech Sector Uncertainty

CARVYKTI Achieves 33% Five-Year Progression-Free Survival in Relapsed Multiple Myeloma

100% left coverage1 source

CARVYKTI Achieves 33% Five-Year Progression-Free Survival in Relapsed Multiple Myeloma

100% left coverage1 source

CARVYKTI Achieves 33% Five-Year Progression-Free Survival in Relapsed Multiple Myeloma

CARVYKTI Achieves 33% Five-Year Progression-Free Survival in Relapsed Multiple Myeloma

Biotech, Markets

Pfizer Secures $6B China Cancer Drug Deal with 3SBio

67% center coverage3 sources

Biotech, Markets

Pfizer Secures $6B China Cancer Drug Deal with 3SBio

67% center coverage3 sources

Pfizer Secures $6B China Cancer Drug Deal with 3SBio

Pfizer Secures $6B China Cancer Drug Deal with 3SBio

Biotech, Voting

Multiple Firms Disclose Voting Rights Ahead 2025 AGMs

100% left coverage1 source

Biotech, Voting

Multiple Firms Disclose Voting Rights Ahead 2025 AGMs

100% left coverage1 source

Multiple Firms Disclose Voting Rights Ahead 2025 AGMs

Multiple Firms Disclose Voting Rights Ahead 2025 AGMs

Biotech, Startups

Regeneron Acquires 23andMe Assets for $256 Million After Bankruptcy

100% left coverage2 sources

Biotech, Startups

Regeneron Acquires 23andMe Assets for $256 Million After Bankruptcy

100% left coverage2 sources

Regeneron Acquires 23andMe Assets for $256 Million After Bankruptcy

Regeneron Acquires 23andMe Assets for $256 Million After Bankruptcy

Ask VT AI

View News Summary

Michelle Obama's new fashion memoir 'The Look' reclaims her personal narrative and explores themes of confidence, identity, and beauty standards.
UK inflation data error overstates April figures, raising concerns about accuracy of economic statistics.
Ciena reports strong revenue growth, but earnings miss expectations as networking segment shines and company sets ambitious 2025 target.

20 hours

First 100 Days

See how you scored in predicting Trump's first 100 days

Most Reported By
News from Biotech